DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model

AUTOR(ES)

Berul, Charles I.

FONTE

American Society for Clinical Investigation

RESUMO

Myotonic dystrophy (DM) is the most common form of muscular dystrophy and is caused by expansion of a CTG trinucleotide repeat on human chromosome 19. Patients with DM develop atrioventricular conduction disturbances, the principal cardiac manifestation of this disease. The etiology of the pathophysiological changes observed in DM has yet to be resolved. Haploinsufficiency of myotonic dystrophy protein kinase (DMPK), DM locus-associated homeodomain protein (DMAHP) and/or titration of RNA-binding proteins by expanded CUG sequences have been hypothesized to underlie the multi-system defects observed in DM. Using an in vivo murine electrophysiology study, we show that cardiac conduction is exquisitely sensitive to DMPK gene dosage. DMPK–/– mice develop cardiac conduction defects which include first-, second-, and third-degree atrioventricular (A–V) block. Our results demonstrate that the A–V node and the His-Purkinje regions of the conduction system are specifically compromised by DMPK loss. Importantly, DMPK+/– mice develop first-degree heart block, a conduction defect strikingly similar to that observed in DM patients. These results demonstrate that DMPK dosage is a critical element modulating cardiac conduction integrity and conclusively link haploinsufficiency of DMPK with cardiac disease in myotonic dystrophy.

Documentos Relacionados

• Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes
• Electrocardiographic abnormalities in patients with myotonic dystrophy.
• Measurement of motor conduction velocity with Hopf's technique in myotonic dystrophy.
• Transcript Level Alterations Reflect Gene Dosage Effects Across Multiple Tissues in a Mouse Model of Down Syndrome
• Myotonic Dystrophy